Healthcare / Drug Manufacturers - Specialty & GenericUpdated 2026-05-10 22:07 UTC

ETR/B8FK stock hub

ETR/B8FK has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

ETR/B8FKis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

14.8M

Deutsche Börse Xetra

Market data

Live price

Current market quote for this ticker.

Current price

ETR/B8FK

In the news

Latest news · ETR/B8FK

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.3P50 15.7P75 20.2

Trailing P/En/a

P25 16.4P50 20.9P75 30.4

ROE-41.1

P25 -6.7P50 8.5P75 17.2

ROIC-8.8

P25 -1.7P50 8.5P75 17.4

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All ETR/B8FK market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

180

Groups with data

Currency

EUR

Showing 180 of 180 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Germany
Country code	DE
Employees	73.61
Employees Change	-5.88%
Employees Change Percent	-7.4
Enterprise value	EUR 11.3M
Exchange	Deutsche Börse Xetra
Financial currency	EUR
First seen	2026-05-10
Industry	Drug Manufacturers - Specialty & Generic
Isin	DE000A4BGGM7
Last refreshed	2026-05-10
Market cap	EUR 14.8M
Price	EUR 2.4
Price currency	EUR
Rev Per Employee	178,229.73x
Sector	Healthcare
Sic	2834
Symbol	etr/B8FK
Website	https://www.biofrontera.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-26.74%
EV Earnings	-2.85x
EV/FCF	-2.54x
EV/Sales	0.86x
FCF yield	-30.02%
P/B ratio	0.99x
P/S ratio	1.12x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-7.77%
EBITDA Margin	-6.38%
Gross margin	82.71%
Gross Profit	EUR 10.9M
Gross Profit Growth	-18.11%
Gross Profit Growth3 Y	-26.22%
Gross Profit Growth5 Y	-18.49%
Net Income	EUR -4M
Net Income Growth Quarters	5%
Pretax Margin	-9.27%
Profit Margin	-30.06%
Profit Per Employee	EUR -53,581
ROA	-2.55
Roa5y	-1.9
ROCE	-6.87
ROE	-41.13
Roe5y	-9.05
ROIC	-8.82
Roic5y	-5.41

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-27.87%
Cagr15y	-18.42%
Cagr1y	5.27%
Cagr3y	-53.74%
Cagr5y	-45.17%
Revenue Growth	-27.43x
Revenue Growth3 Y	-25.75x
Revenue Growth5 Y	-16.78x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	EUR 0.52
Assets	EUR 20.6M
Cash	EUR 3.6M
Current Assets	EUR 13.9M
Current Liabilities	EUR 5.7M
Debt	EUR 65,000
Debt Equity	EUR 0
Debt FCF	EUR -0.01
Equity	EUR 14.9M
Interest Coverage	-73.21
Liabilities	EUR 5.7M
Long Term Assets	EUR 6.7M
Long Term Liabilities	EUR 7,000
Net Cash	EUR 3.5M
Net Cash By Market Cap	EUR 23.86
Net Cash Growth	244.5%
Net Debt Equity	EUR -0.24
Tangible Book Value	EUR 14.9M
Tangible Book Value Per Share	EUR 2.45
WACC	3.39

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	2.43
Inventory Turnover	0.49
Net Working Capital	EUR 4.6M
Quick ratio	1.65
Working Capital	EUR 8.2M
Working Capital Turnover	EUR 1.87

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-13.3%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-96.19%
1Y total return	5.26%
200-day SMA	2.62
3Y total return	-90.11%
50-day SMA	2.57
50-day SMA vs 200-day SMA	50under200
5Y total return	-95.04%
All Time High	341.3
All Time High Change	-99.3%
All Time High Date	2007-02-07
All Time Low	2.08
All Time Low Change	15.38%
All Time Low Date	2024-12-30
ATR	0.13
Beta	-0.17
Beta1y	-0.09
Beta2y	-0.14
Ch YTD	-1.64
High	2.5
High52	2.96
High52 Date	2025-11-04
High52ch	-18.92%
Low	2.37
Low52	2.16
Low52 Date	2025-06-02
Low52ch	11.11%
Ma50ch	-6.51%
Price vs 200-day SMA	-8.36%
RSI	45.44
RSI Monthly	27.17
RSI Weekly	42.09
Sharpe ratio	-0.09x
Sortino ratio	0.02
Total Return	-13.3%
Tr YTD	-1.64
Tr15y	-95.28%
Tr1m	-6.61%
Tr1w	-3.61%
Tr3m	-0.83%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	EUR -1M
Operating margin	-7.77

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	1,397,566%
Net Borrowing	-438,000
Shares Out	6,076,862
Shares Yo Y	13.3%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	EUR -4.5M
Average Volume	987x
Bv Per Share	2.45
CAPEX	EUR -51,000
Ch10y	-96.62
Ch15y	-96.19
Ch1m	-6.61
Ch1w	-3.61
Ch1y	5.26
Ch3m	-0.83
Ch3y	-90.11
Ch5y	-95.26
Ch6m	-13.04
Change	-0.41%
Change From Open	-4
Close	2.41
Days Gap	3.73
Depreciation Amortization	183,000
Dollar Volume	324
Earnings Date	2026-04-17
EBIT	EUR -1M
EBITDA	EUR -842,000
EPS	EUR -0.65
F Score	2
FCF	EUR -4.5M
FCF EV Yield	-39.43x
FCF Per Share	EUR -0.73
Financing CF	-452,000
Fiscal Year End	December
Founded	1,997
Income Tax	EUR 5.7M
Investing CF	5,331,000
Is Primary Listing	1
Last Earnings Date	2026-04-17
Last Report Date	2025-12-31
Last Split Date	2024-05-14
Last Split Type	Reverse
Ma150	2.6
Ma150ch	-7.73%
Ma20	2.5
Ma20ch	-3.96%
Net CF	479,000
Next Earnings Date	2026-05-31
Open	2.5
Position In Range	23.08
Ppne	660,000
Price Date	2026-05-08
Ptbv Ratio	1
Relative Volume	0.16x
Revenue	13,189,000x
Tax By Revenue	43.38x
Tr6m	-13.04%
Volume	135
Z Score	-6.16

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does ETR/B8FK pay a dividend?

Capital-return profile for this ticker.

Performance

ETR/B8FK stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns ETR/B8FK?

Insider, institutional, and short-interest positioning.

Institutional ownership

n/a

Share of float held by funds and institutions

Insider ownership

n/a

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+13.3%

Negative means the company is buying back shares.

Technical

ETR/B8FK momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

45.4

Neutral momentum band

Price vs 200-day MA

-8.4%

50/200-day relationship not available

Beta (5Y)

-0.17

Less volatile than the market

Sharpe ratio

-0.09

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About ETR/B8FK

Hub-level FAQ points readers to the deeper analysis pages.

What is the current etr/B8FK stock rating?

etr/B8FK is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full etr/B8FK analysis?

The full report lives at /stocks/etr/B8FK/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for etr/B8FK?

The latest report frames etr/B8FK around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the etr/B8FK page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.